177 related articles for article (PubMed ID: 29777297)
1. Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial.
Loffi M; Tousek P; Budesinsky T; Lisa L; Santangelo A; Widimsky P; Kocka V
Heart Vessels; 2018 Nov; 33(11):1282-1287. PubMed ID: 29777297
[TBL] [Abstract][Full Text] [Related]
2. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold.
Koltowski L; Tomaniak M; Ochijewicz D; Zieliński K; Proniewska K; Malinowski KP; Zaleska M; Maksym J; Roleder T; Partyka L; Kochman W; Filipiak KJ; Opolski G; Kochman J
Am J Cardiol; 2021 Sep; 155():23-31. PubMed ID: 34315572
[TBL] [Abstract][Full Text] [Related]
3. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.
Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P
Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128
[TBL] [Abstract][Full Text] [Related]
4. Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.
Gutiérrez-Chico JL; Cortés C; Schincariol M; Limon U; Yalcinli M; Durán-Cortés MA; Jaguszewski M
Cardiol J; 2018; 25(4):443-458. PubMed ID: 29774520
[TBL] [Abstract][Full Text] [Related]
5. Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.
Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Röther J; Tröbs M; Schlundt C; Achenbach S; Hamm CW; Nef HM
Clin Res Cardiol; 2017 Apr; 106(4):271-279. PubMed ID: 27757522
[TBL] [Abstract][Full Text] [Related]
6. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold.
Kochman J; Kołtowski Ł; Tomaniak M; Jąkała J; Proniewska K; Legutko J; Roleder T; Piertrasik A; Rdzanek A; Kochman W; Brugaletta S; Opolski G; Regar E
EuroIntervention; 2018 Apr; 13(18):e2201-e2209. PubMed ID: 29155384
[TBL] [Abstract][Full Text] [Related]
7. Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report.
Karanasos A; Muramatsu T; Diletti R; Nauta S; Onuma Y; Lenzen M; Nakatani S; Van Mieghem NM; Schultz C; De Jaegere PP; Serruys PW; Zijlstra F; Regar E; van Geuns RJ
Hellenic J Cardiol; 2015; 56(2):125-35. PubMed ID: 25854441
[TBL] [Abstract][Full Text] [Related]
8. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
[TBL] [Abstract][Full Text] [Related]
9. Bioresorbable everolimus-eluting vascular scaffold in patients with ST-segment elevation myocardial infarction: Optical coherence tomography evaluation and clinical outcomes.
Kochman J; Tomaniak M; Pietrasik A; Kołtowski Ł; Rdzanek A; Huczek Z; Mazurek T; Jąkała J; Ząbek A; Legutko J; Kochman W; Filipiak KJ
Cardiol J; 2015; 22(3):315-22. PubMed ID: 25428734
[TBL] [Abstract][Full Text] [Related]
10. Peri-strut low intensity areas and in-scaffold neointima growth after bioresorbable scaffold implantation in STEMI. A serial optical coherence tomography study.
Ochijewicz D; Tomaniak M; Kołtowski L; Rdzanek A; Pietrasik A; Proniewska K; Partyka L; Dijsktra J; Huczek Z; Filipiak K; Opolski G; Kochman J
Int J Cardiol; 2020 Aug; 312():27-32. PubMed ID: 32315682
[TBL] [Abstract][Full Text] [Related]
11. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
[TBL] [Abstract][Full Text] [Related]
12. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.
Diletti R; Karanasos A; Muramatsu T; Nakatani S; Van Mieghem NM; Onuma Y; Nauta ST; Ishibashi Y; Lenzen MJ; Ligthart J; Schultz C; Regar E; de Jaegere PP; Serruys PW; Zijlstra F; van Geuns RJ
Eur Heart J; 2014 Mar; 35(12):777-86. PubMed ID: 24394380
[TBL] [Abstract][Full Text] [Related]
13. Optical Coherence Tomography- Versus Angiography-Guided Magnesium Bioresorbable Scaffold Implantation in NSTEMI Patients.
Fallesen CO; Antonsen L; Maehara A; Noori M; Hougaard M; Hansen KN; Ellert J; Ahlehoff O; Veien KT; Lassen JF; Junker AB; Hansen HS; Jensen LO
Cardiovasc Revasc Med; 2022 Jul; 40():101-110. PubMed ID: 34949544
[TBL] [Abstract][Full Text] [Related]
14. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
15. Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
Yahagi K; Virmani R; Kesavamoorthy B
Cardiovasc Interv Ther; 2017 Jan; 32(1):53-55. PubMed ID: 26521263
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
[TBL] [Abstract][Full Text] [Related]
17. Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction: The snowshoe effect: Insights from the maximal footprint analysis.
Diletti R; van der Sijde J; Karanasos A; Fam JM; Felix C; van Mieghem NM; Regar E; Rapoza R; Zijlstra F; van Geuns RJ
Int J Cardiol; 2016 Oct; 220():802-8. PubMed ID: 27394977
[TBL] [Abstract][Full Text] [Related]
18. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
[TBL] [Abstract][Full Text] [Related]
19. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'.
Kočka V; Malý M; Toušek P; Buděšínský T; Lisa L; Prodanov P; Jarkovský J; Widimský P
Eur Heart J; 2014 Mar; 35(12):787-94. PubMed ID: 24419808
[TBL] [Abstract][Full Text] [Related]
20. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
